| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phthalic Acids | 63 | 2022 | 436 | 10.140 |
Why?
|
| Environmental Pollutants | 79 | 2022 | 1179 | 8.220 |
Why?
|
| Environmental Exposure | 86 | 2021 | 4232 | 5.940 |
Why?
|
| Phenols | 36 | 2021 | 497 | 5.830 |
Why?
|
| Polychlorinated Biphenyls | 25 | 2021 | 245 | 5.490 |
Why?
|
| Parabens | 19 | 2021 | 108 | 5.060 |
Why?
|
| Infertility, Male | 29 | 2019 | 409 | 4.860 |
Why?
|
| Fertilization in Vitro | 40 | 2021 | 1284 | 4.290 |
Why?
|
| Semen | 24 | 2022 | 316 | 4.160 |
Why?
|
| Dioxins | 12 | 2021 | 102 | 3.990 |
Why?
|
| Spermatozoa | 30 | 2021 | 625 | 3.630 |
Why?
|
| Endocrine Disruptors | 21 | 2021 | 237 | 3.300 |
Why?
|
| Insecticides | 14 | 2017 | 195 | 2.690 |
Why?
|
| Benzhydryl Compounds | 31 | 2021 | 845 | 2.640 |
Why?
|
| Flame Retardants | 13 | 2021 | 87 | 2.620 |
Why?
|
| Maternal Exposure | 27 | 2021 | 961 | 2.540 |
Why?
|
| Sperm Count | 22 | 2022 | 216 | 2.500 |
Why?
|
| Reproductive Techniques, Assisted | 25 | 2021 | 482 | 2.470 |
Why?
|
| Diethylhexyl Phthalate | 16 | 2021 | 81 | 2.450 |
Why?
|
| Sperm Motility | 22 | 2022 | 253 | 2.380 |
Why?
|
| Dibutyl Phthalate | 6 | 2019 | 30 | 2.170 |
Why?
|
| Pesticides | 13 | 2020 | 287 | 2.130 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 9 | 2015 | 88 | 2.040 |
Why?
|
| Hydrocarbons, Chlorinated | 8 | 2020 | 128 | 1.980 |
Why?
|
| Puberty | 10 | 2019 | 490 | 1.930 |
Why?
|
| Thyroid Hormones | 9 | 2020 | 390 | 1.920 |
Why?
|
| Russia | 23 | 2021 | 408 | 1.860 |
Why?
|
| Infertility | 18 | 2021 | 655 | 1.830 |
Why?
|
| Plasticizers | 10 | 2019 | 47 | 1.810 |
Why?
|
| Semen Analysis | 17 | 2022 | 204 | 1.800 |
Why?
|
| Pregnancy Outcome | 25 | 2021 | 2795 | 1.680 |
Why?
|
| Infertility, Female | 15 | 2020 | 788 | 1.670 |
Why?
|
| Hexachlorobenzene | 7 | 2015 | 30 | 1.670 |
Why?
|
| Cosmetics | 6 | 2019 | 97 | 1.620 |
Why?
|
| Fertility | 18 | 2021 | 781 | 1.590 |
Why?
|
| Pregnancy | 116 | 2022 | 29144 | 1.460 |
Why?
|
| Preservatives, Pharmaceutical | 3 | 2015 | 31 | 1.410 |
Why?
|
| Environmental Monitoring | 27 | 2021 | 1414 | 1.380 |
Why?
|
| Sexual Maturation | 5 | 2019 | 265 | 1.360 |
Why?
|
| Mesalamine | 7 | 2019 | 136 | 1.290 |
Why?
|
| Live Birth | 16 | 2021 | 512 | 1.230 |
Why?
|
| Follicular Fluid | 8 | 2021 | 87 | 1.210 |
Why?
|
| Lead | 7 | 2022 | 852 | 1.200 |
Why?
|
| Abortion, Spontaneous | 9 | 2020 | 544 | 1.170 |
Why?
|
| Reproduction | 10 | 2021 | 668 | 1.140 |
Why?
|
| Pesticide Residues | 7 | 2021 | 95 | 1.140 |
Why?
|
| Embryo Implantation | 8 | 2016 | 272 | 1.090 |
Why?
|
| DNA Damage | 11 | 2019 | 2432 | 1.040 |
Why?
|
| Halogenated Diphenyl Ethers | 10 | 2021 | 77 | 1.030 |
Why?
|
| Carbaryl | 5 | 2007 | 8 | 1.000 |
Why?
|
| Adult | 207 | 2022 | 214052 | 1.000 |
Why?
|
| Furans | 4 | 2021 | 194 | 0.980 |
Why?
|
| Fluorocarbons | 8 | 2021 | 452 | 0.980 |
Why?
|
| Paternal Exposure | 7 | 2021 | 89 | 0.960 |
Why?
|
| Follicle Stimulating Hormone | 11 | 2019 | 744 | 0.950 |
Why?
|
| Prenatal Exposure Delayed Effects | 14 | 2021 | 2408 | 0.940 |
Why?
|
| Prospective Studies | 84 | 2022 | 53290 | 0.920 |
Why?
|
| Gonadotropins, Pituitary | 2 | 2017 | 73 | 0.910 |
Why?
|
| Hazardous Substances | 3 | 2019 | 149 | 0.880 |
Why?
|
| Quinolinic Acid | 2 | 2020 | 67 | 0.870 |
Why?
|
| Ovarian Follicle | 5 | 2021 | 248 | 0.870 |
Why?
|
| Triclosan | 7 | 2019 | 55 | 0.860 |
Why?
|
| Pyrethrins | 3 | 2017 | 47 | 0.810 |
Why?
|
| Naphthols | 5 | 2014 | 45 | 0.800 |
Why?
|
| Dust | 5 | 2021 | 482 | 0.800 |
Why?
|
| Oocytes | 7 | 2020 | 1188 | 0.780 |
Why?
|
| Male | 195 | 2022 | 350115 | 0.780 |
Why?
|
| Humans | 316 | 2022 | 744366 | 0.780 |
Why?
|
| Alkanesulfonic Acids | 5 | 2021 | 180 | 0.760 |
Why?
|
| Air Pollutants | 13 | 2021 | 2816 | 0.750 |
Why?
|
| Inhibins | 8 | 2011 | 211 | 0.730 |
Why?
|
| Air Pollution, Indoor | 9 | 2021 | 857 | 0.720 |
Why?
|
| Mercury | 3 | 2021 | 285 | 0.710 |
Why?
|
| Hair | 3 | 2017 | 481 | 0.710 |
Why?
|
| Chlorpyrifos | 4 | 2007 | 19 | 0.710 |
Why?
|
| Pregnancy Rate | 13 | 2020 | 643 | 0.680 |
Why?
|
| Sex Hormone-Binding Globulin | 8 | 2013 | 548 | 0.670 |
Why?
|
| Female | 198 | 2022 | 380193 | 0.670 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 1622 | 0.660 |
Why?
|
| Linear Models | 20 | 2019 | 5953 | 0.630 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 29 | 0.620 |
Why?
|
| Gonadal Steroid Hormones | 5 | 2016 | 711 | 0.620 |
Why?
|
| Body Mass Index | 22 | 2020 | 12721 | 0.620 |
Why?
|
| Comet Assay | 6 | 2008 | 71 | 0.610 |
Why?
|
| Nutrition Surveys | 8 | 2021 | 1660 | 0.610 |
Why?
|
| Vehicle Emissions | 3 | 2019 | 665 | 0.600 |
Why?
|
| Endocrine Glands | 1 | 2017 | 103 | 0.600 |
Why?
|
| European Union | 2 | 2015 | 158 | 0.600 |
Why?
|
| Product Packaging | 1 | 2017 | 23 | 0.600 |
Why?
|
| Automobiles | 1 | 2018 | 116 | 0.600 |
Why?
|
| Occupational Exposure | 14 | 2017 | 1793 | 0.590 |
Why?
|
| Soy Foods | 3 | 2016 | 48 | 0.580 |
Why?
|
| Leiomyoma | 5 | 2021 | 730 | 0.570 |
Why?
|
| Luteinizing Hormone | 7 | 2022 | 869 | 0.560 |
Why?
|
| Estradiol | 8 | 2020 | 2020 | 0.560 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2018 | 2282 | 0.550 |
Why?
|
| Testosterone | 11 | 2021 | 2419 | 0.540 |
Why?
|
| Folic Acid | 6 | 2019 | 1300 | 0.530 |
Why?
|
| Urine | 3 | 2015 | 370 | 0.530 |
Why?
|
| Growth | 2 | 2010 | 376 | 0.520 |
Why?
|
| Hormones | 3 | 2012 | 889 | 0.510 |
Why?
|
| Young Adult | 55 | 2021 | 56429 | 0.500 |
Why?
|
| Cohort Studies | 45 | 2022 | 40559 | 0.500 |
Why?
|
| Pyridones | 4 | 2007 | 711 | 0.500 |
Why?
|
| Prediabetic State | 4 | 2021 | 499 | 0.490 |
Why?
|
| Seafood | 5 | 2020 | 384 | 0.490 |
Why?
|
| o-Phthalaldehyde | 1 | 2014 | 16 | 0.480 |
Why?
|
| Benzophenones | 4 | 2020 | 57 | 0.480 |
Why?
|
| Fruit | 6 | 2021 | 1142 | 0.480 |
Why?
|
| Massachusetts | 20 | 2020 | 8662 | 0.480 |
Why?
|
| Estrogens, Non-Steroidal | 3 | 2015 | 54 | 0.480 |
Why?
|
| Vegetables | 6 | 2021 | 1182 | 0.470 |
Why?
|
| Birth Weight | 6 | 2019 | 2069 | 0.470 |
Why?
|
| Paper | 1 | 2014 | 85 | 0.470 |
Why?
|
| Premature Birth | 6 | 2021 | 1721 | 0.470 |
Why?
|
| Housing | 2 | 2018 | 664 | 0.470 |
Why?
|
| Benzofurans | 2 | 2011 | 140 | 0.460 |
Why?
|
| Ovulation Induction | 7 | 2020 | 274 | 0.450 |
Why?
|
| Adolescent | 55 | 2022 | 85779 | 0.450 |
Why?
|
| Antimony | 1 | 2012 | 19 | 0.450 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2021 | 402 | 0.440 |
Why?
|
| Naphthalenes | 3 | 2014 | 194 | 0.430 |
Why?
|
| Food Preservatives | 1 | 2012 | 11 | 0.430 |
Why?
|
| Disinfectants | 1 | 2014 | 116 | 0.430 |
Why?
|
| Dental Restoration, Permanent | 4 | 2014 | 127 | 0.430 |
Why?
|
| Boston | 18 | 2020 | 9312 | 0.410 |
Why?
|
| Ovary | 2 | 2013 | 981 | 0.410 |
Why?
|
| Middle Aged | 84 | 2021 | 213390 | 0.410 |
Why?
|
| Genitalia, Male | 4 | 2019 | 84 | 0.410 |
Why?
|
| Marijuana Smoking | 3 | 2019 | 253 | 0.410 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 4 | 2016 | 378 | 0.400 |
Why?
|
| Air Pollution | 6 | 2020 | 2286 | 0.400 |
Why?
|
| Blood Glucose | 8 | 2021 | 6254 | 0.400 |
Why?
|
| Cross-Sectional Studies | 33 | 2021 | 25039 | 0.390 |
Why?
|
| Herbicides | 2 | 2017 | 100 | 0.380 |
Why?
|
| Child | 41 | 2022 | 77709 | 0.380 |
Why?
|
| Androgens | 4 | 2021 | 1281 | 0.380 |
Why?
|
| Carbanilides | 2 | 2021 | 17 | 0.380 |
Why?
|
| Chromatography, High Pressure Liquid | 8 | 2018 | 1572 | 0.360 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2013 | 781 | 0.360 |
Why?
|
| Labor Onset | 1 | 2009 | 16 | 0.360 |
Why?
|
| Fishes | 4 | 2018 | 569 | 0.360 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 290 | 0.360 |
Why?
|
| Pregnancy Trimester, First | 6 | 2022 | 853 | 0.350 |
Why?
|
| MicroRNAs | 7 | 2021 | 3751 | 0.350 |
Why?
|
| Caprylates | 3 | 2019 | 111 | 0.350 |
Why?
|
| Diet | 15 | 2021 | 7937 | 0.350 |
Why?
|
| Trans Fatty Acids | 1 | 2010 | 153 | 0.350 |
Why?
|
| Longitudinal Studies | 20 | 2021 | 13991 | 0.340 |
Why?
|
| Puberty, Delayed | 1 | 2010 | 115 | 0.340 |
Why?
|
| Oocyte Retrieval | 5 | 2020 | 161 | 0.340 |
Why?
|
| Gestational Age | 7 | 2021 | 3493 | 0.340 |
Why?
|
| Composite Resins | 3 | 2014 | 74 | 0.340 |
Why?
|
| Testicular Neoplasms | 3 | 2021 | 806 | 0.340 |
Why?
|
| Child Development | 5 | 2021 | 2223 | 0.330 |
Why?
|
| Cross-Over Studies | 8 | 2017 | 2029 | 0.330 |
Why?
|
| Pharmaceutical Preparations | 3 | 2011 | 1070 | 0.330 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 242 | 0.330 |
Why?
|
| Cost of Illness | 2 | 2015 | 1860 | 0.320 |
Why?
|
| Diabetes, Gestational | 6 | 2022 | 1184 | 0.320 |
Why?
|
| Fathers | 3 | 2019 | 358 | 0.320 |
Why?
|
| Hypersensitivity | 2 | 2017 | 1102 | 0.320 |
Why?
|
| Models, Statistical | 3 | 2016 | 5101 | 0.320 |
Why?
|
| Air Pollutants, Occupational | 6 | 2008 | 408 | 0.320 |
Why?
|
| Occupational Diseases | 6 | 2017 | 1469 | 0.310 |
Why?
|
| beta Carotene | 2 | 2019 | 527 | 0.310 |
Why?
|
| Dairy Products | 3 | 2017 | 498 | 0.310 |
Why?
|
| Particulate Matter | 8 | 2021 | 2529 | 0.310 |
Why?
|
| Preconception Care | 3 | 2019 | 134 | 0.310 |
Why?
|
| Lead Poisoning | 1 | 2010 | 301 | 0.310 |
Why?
|
| Data Interpretation, Statistical | 4 | 2019 | 2716 | 0.310 |
Why?
|
| Isoflavones | 1 | 2008 | 139 | 0.300 |
Why?
|
| Water Pollutants, Chemical | 3 | 2017 | 311 | 0.300 |
Why?
|
| Benzoates | 1 | 2009 | 217 | 0.300 |
Why?
|
| Thyroxine | 2 | 2008 | 667 | 0.290 |
Why?
|
| Regression Analysis | 12 | 2017 | 6459 | 0.290 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2006 | 29 | 0.280 |
Why?
|
| Eating | 4 | 2018 | 1536 | 0.280 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 2016 | 0.280 |
Why?
|
| Andrology | 2 | 2005 | 10 | 0.280 |
Why?
|
| Food Contamination | 3 | 2019 | 188 | 0.280 |
Why?
|
| Urban Population | 2 | 2016 | 2022 | 0.280 |
Why?
|
| Granulosa Cells | 2 | 2019 | 121 | 0.270 |
Why?
|
| Hand Injuries | 6 | 2005 | 242 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2021 | 11726 | 0.270 |
Why?
|
| Seasons | 3 | 2020 | 1493 | 0.270 |
Why?
|
| Cryptorchidism | 2 | 2018 | 125 | 0.270 |
Why?
|
| Environmental Health | 1 | 2008 | 278 | 0.260 |
Why?
|
| RNA | 4 | 2019 | 2749 | 0.260 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2018 | 1157 | 0.260 |
Why?
|
| Chemical Industry | 1 | 2005 | 114 | 0.260 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 577 | 0.260 |
Why?
|
| Inhalation Exposure | 6 | 2008 | 443 | 0.250 |
Why?
|
| Accidents, Occupational | 5 | 2010 | 251 | 0.240 |
Why?
|
| Arsenic | 2 | 2017 | 328 | 0.240 |
Why?
|
| Plastics | 2 | 2017 | 123 | 0.240 |
Why?
|
| Body Weight | 6 | 2018 | 4671 | 0.240 |
Why?
|
| Embryo Transfer | 5 | 2020 | 510 | 0.240 |
Why?
|
| Pit and Fissure Sealants | 2 | 2014 | 27 | 0.240 |
Why?
|
| Age Factors | 11 | 2020 | 18373 | 0.230 |
Why?
|
| Household Products | 2 | 2019 | 26 | 0.230 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2007 | 816 | 0.230 |
Why?
|
| Dietary Supplements | 7 | 2019 | 3296 | 0.230 |
Why?
|
| Pollen | 1 | 2003 | 75 | 0.220 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 501 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 5 | 2021 | 2012 | 0.220 |
Why?
|
| Pilot Projects | 8 | 2019 | 8319 | 0.220 |
Why?
|
| Fertilization | 4 | 2019 | 196 | 0.220 |
Why?
|
| Infant, Newborn | 20 | 2021 | 25628 | 0.220 |
Why?
|
| Multivariate Analysis | 10 | 2019 | 12244 | 0.220 |
Why?
|
| Sperm Injections, Intracytoplasmic | 4 | 2019 | 160 | 0.220 |
Why?
|
| Thyrotropin | 3 | 2020 | 849 | 0.210 |
Why?
|
| Equipment and Supplies | 3 | 2013 | 281 | 0.210 |
Why?
|
| Dietary Proteins | 2 | 2018 | 963 | 0.210 |
Why?
|
| Dental Amalgam | 2 | 2012 | 67 | 0.210 |
Why?
|
| Feeding Behavior | 4 | 2018 | 3188 | 0.210 |
Why?
|
| Organophosphorus Compounds | 3 | 2016 | 215 | 0.210 |
Why?
|
| Odds Ratio | 10 | 2021 | 9849 | 0.210 |
Why?
|
| Women's Health | 4 | 2021 | 2034 | 0.210 |
Why?
|
| Oogenesis | 2 | 2019 | 131 | 0.200 |
Why?
|
| Gloves, Protective | 3 | 2014 | 22 | 0.200 |
Why?
|
| Reproductive Techniques | 1 | 2021 | 42 | 0.200 |
Why?
|
| Bronchitis | 1 | 2002 | 200 | 0.200 |
Why?
|
| Self Report | 6 | 2019 | 3553 | 0.200 |
Why?
|
| Life Style | 7 | 2021 | 3835 | 0.200 |
Why?
|
| Stillbirth | 2 | 2014 | 346 | 0.200 |
Why?
|
| Nitrogen Dioxide | 3 | 2020 | 490 | 0.200 |
Why?
|
| Reference Values | 5 | 2014 | 4982 | 0.200 |
Why?
|
| Aromatase | 2 | 2013 | 147 | 0.190 |
Why?
|
| Obesity | 9 | 2021 | 12746 | 0.190 |
Why?
|
| Body Height | 3 | 2017 | 1578 | 0.190 |
Why?
|
| Risk Factors | 31 | 2021 | 72296 | 0.190 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 319 | 0.190 |
Why?
|
| Weight Loss | 1 | 2012 | 2625 | 0.190 |
Why?
|
| Biotransformation | 2 | 2012 | 168 | 0.190 |
Why?
|
| Sulfones | 2 | 2021 | 436 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2019 | 10943 | 0.180 |
Why?
|
| Metals | 4 | 2008 | 719 | 0.180 |
Why?
|
| Omeprazole | 2 | 2013 | 112 | 0.180 |
Why?
|
| Dicarboxylic Acids | 2 | 2018 | 69 | 0.180 |
Why?
|
| Logistic Models | 11 | 2020 | 13409 | 0.180 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2014 | 392 | 0.180 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2003 | 337 | 0.180 |
Why?
|
| Cadmium | 2 | 2013 | 212 | 0.180 |
Why?
|
| Body Composition | 2 | 2019 | 2402 | 0.180 |
Why?
|
| Risk Assessment | 15 | 2021 | 23336 | 0.180 |
Why?
|
| Perimenopause | 1 | 2021 | 139 | 0.180 |
Why?
|
| Meat | 2 | 2015 | 592 | 0.180 |
Why?
|
| Toxicity Tests | 2 | 2019 | 121 | 0.180 |
Why?
|
| Time Factors | 18 | 2019 | 40075 | 0.180 |
Why?
|
| Michigan | 4 | 2021 | 350 | 0.180 |
Why?
|
| Soaps | 1 | 2019 | 28 | 0.180 |
Why?
|
| Pregnancy Trimester, Second | 6 | 2020 | 732 | 0.170 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2019 | 32 | 0.170 |
Why?
|
| Infant, Premature | 1 | 2008 | 2045 | 0.170 |
Why?
|
| Reproductive Medicine | 2 | 2019 | 108 | 0.170 |
Why?
|
| Placenta | 3 | 2016 | 1699 | 0.160 |
Why?
|
| Electromagnetic Fields | 1 | 2020 | 298 | 0.160 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 132 | 0.160 |
Why?
|
| Ozone | 2 | 2020 | 469 | 0.160 |
Why?
|
| Hot Flashes | 1 | 2021 | 316 | 0.160 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2019 | 456 | 0.160 |
Why?
|
| Lacerations | 3 | 2010 | 144 | 0.150 |
Why?
|
| Hypospadias | 1 | 2018 | 92 | 0.150 |
Why?
|
| Bayes Theorem | 6 | 2021 | 2307 | 0.150 |
Why?
|
| Particle Size | 11 | 2008 | 1642 | 0.150 |
Why?
|
| Prolactin | 2 | 2010 | 669 | 0.150 |
Why?
|
| Uterine Neoplasms | 2 | 2021 | 1513 | 0.150 |
Why?
|
| Breast Feeding | 3 | 2019 | 1338 | 0.150 |
Why?
|
| Polypropylenes | 1 | 2017 | 64 | 0.150 |
Why?
|
| Military Personnel | 1 | 2006 | 1133 | 0.150 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 288 | 0.150 |
Why?
|
| Spermatogenesis | 4 | 2019 | 262 | 0.150 |
Why?
|
| Osmolar Concentration | 2 | 2010 | 683 | 0.140 |
Why?
|
| Dietary Fats | 3 | 2016 | 2016 | 0.140 |
Why?
|
| Glass | 1 | 2017 | 114 | 0.140 |
Why?
|
| Policy Making | 1 | 2021 | 554 | 0.140 |
Why?
|
| Spectrophotometry, Atomic | 2 | 2013 | 81 | 0.140 |
Why?
|
| Sensitivity and Specificity | 5 | 2011 | 14723 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2018 | 370 | 0.140 |
Why?
|
| Pregnancy Complications | 3 | 2020 | 2861 | 0.140 |
Why?
|
| Lifting | 1 | 2017 | 56 | 0.140 |
Why?
|
| Diet Surveys | 5 | 2019 | 1173 | 0.140 |
Why?
|
| Animals | 29 | 2021 | 168768 | 0.140 |
Why?
|
| Food Handling | 3 | 2015 | 145 | 0.140 |
Why?
|
| Bisphenol A-Glycidyl Methacrylate | 2 | 2014 | 15 | 0.140 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 651 | 0.140 |
Why?
|
| Carbon Monoxide | 2 | 2016 | 531 | 0.140 |
Why?
|
| Spouses | 1 | 2018 | 286 | 0.140 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 550 | 0.140 |
Why?
|
| Marriage | 1 | 2017 | 339 | 0.140 |
Why?
|
| Blastocyst | 1 | 2019 | 424 | 0.130 |
Why?
|
| Asthma | 4 | 2013 | 6010 | 0.130 |
Why?
|
| Allergens | 1 | 2003 | 1320 | 0.130 |
Why?
|
| Obesity, Abdominal | 1 | 2019 | 361 | 0.130 |
Why?
|
| Milk, Human | 2 | 2014 | 490 | 0.130 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2016 | 141 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2019 | 729 | 0.130 |
Why?
|
| Confidence Intervals | 3 | 2014 | 2971 | 0.130 |
Why?
|
| Fuel Oils | 2 | 2005 | 34 | 0.130 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 2015 | 18 | 0.130 |
Why?
|
| Pectinidae | 1 | 2015 | 5 | 0.130 |
Why?
|
| Infant Equipment | 1 | 2015 | 24 | 0.130 |
Why?
|
| Rural Health | 1 | 2017 | 305 | 0.130 |
Why?
|
| Triiodothyronine | 2 | 2008 | 494 | 0.130 |
Why?
|
| Eunuchism | 1 | 2015 | 19 | 0.130 |
Why?
|
| Feminine Hygiene Products | 1 | 2014 | 3 | 0.130 |
Why?
|
| Construction Materials | 2 | 2007 | 60 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 4 | 2017 | 934 | 0.130 |
Why?
|
| Hypothyroidism | 1 | 2020 | 658 | 0.130 |
Why?
|
| Endocrine System Diseases | 2 | 2015 | 248 | 0.130 |
Why?
|
| Waist Circumference | 1 | 2019 | 917 | 0.130 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 192 | 0.130 |
Why?
|
| Play and Playthings | 1 | 2015 | 79 | 0.130 |
Why?
|
| Academic Medical Centers | 6 | 2019 | 2760 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 2428 | 0.120 |
Why?
|
| Consumer Product Safety | 1 | 2015 | 122 | 0.120 |
Why?
|
| Functional Food | 1 | 2014 | 20 | 0.120 |
Why?
|
| Antioxidants | 2 | 2019 | 1659 | 0.120 |
Why?
|
| Chromatography, Gas | 2 | 2012 | 156 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 658 | 0.120 |
Why?
|
| Heart Rate | 4 | 2008 | 4092 | 0.120 |
Why?
|
| Epidemiologic Studies | 3 | 2018 | 676 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2018 | 7785 | 0.120 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39052 | 0.120 |
Why?
|
| Meat Products | 1 | 2014 | 99 | 0.120 |
Why?
|
| Occupations | 3 | 2005 | 517 | 0.120 |
Why?
|
| Semen Preservation | 1 | 2013 | 35 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2019 | 3864 | 0.110 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2373 | 0.110 |
Why?
|
| Dental Materials | 1 | 2014 | 108 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2020 | 1173 | 0.110 |
Why?
|
| Sex Factors | 5 | 2021 | 10400 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2011 | 361 | 0.110 |
Why?
|
| Menopause | 1 | 2021 | 1626 | 0.110 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 15160 | 0.110 |
Why?
|
| Endpoint Determination | 3 | 2015 | 601 | 0.110 |
Why?
|
| Cannabis | 1 | 2019 | 440 | 0.110 |
Why?
|
| Resin Cements | 1 | 2012 | 33 | 0.110 |
Why?
|
| Amitriptyline | 1 | 2013 | 110 | 0.110 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 19905 | 0.110 |
Why?
|
| Luminescence | 1 | 2013 | 137 | 0.110 |
Why?
|
| Polyethylene Terephthalates | 1 | 2012 | 116 | 0.110 |
Why?
|
| Work Schedule Tolerance | 1 | 2017 | 563 | 0.110 |
Why?
|
| Exercise | 3 | 2020 | 5615 | 0.110 |
Why?
|
| Fetus | 1 | 2020 | 1880 | 0.110 |
Why?
|
| Body Size | 2 | 2018 | 461 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 527 | 0.110 |
Why?
|
| Free Radical Scavengers | 2 | 2003 | 216 | 0.110 |
Why?
|
| Rats | 8 | 2019 | 24252 | 0.100 |
Why?
|
| Methacrylates | 1 | 2012 | 107 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2011 | 12356 | 0.100 |
Why?
|
| Polyurethanes | 1 | 2012 | 107 | 0.100 |
Why?
|
| DDT | 1 | 2011 | 31 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 1344 | 0.100 |
Why?
|
| PPAR gamma | 2 | 2019 | 493 | 0.100 |
Why?
|
| Power Plants | 4 | 2005 | 119 | 0.100 |
Why?
|
| Carbidopa | 1 | 2011 | 31 | 0.100 |
Why?
|
| Excipients | 1 | 2011 | 96 | 0.100 |
Why?
|
| Body Burden | 2 | 2019 | 158 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 199 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2019 | 1357 | 0.100 |
Why?
|
| Infant Formula | 1 | 2013 | 199 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 7721 | 0.100 |
Why?
|
| Astrocytes | 1 | 2019 | 1273 | 0.100 |
Why?
|
| Learning | 2 | 2018 | 1711 | 0.100 |
Why?
|
| Child Behavior | 2 | 2014 | 839 | 0.100 |
Why?
|
| Geography | 1 | 2013 | 669 | 0.100 |
Why?
|
| Body Weights and Measures | 2 | 2008 | 211 | 0.100 |
Why?
|
| Food-Processing Industry | 1 | 2010 | 15 | 0.100 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 405 | 0.100 |
Why?
|
| Memory | 2 | 2018 | 2174 | 0.100 |
Why?
|
| Occupational Health | 3 | 2008 | 808 | 0.090 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 905 | 0.090 |
Why?
|
| Nonprescription Drugs | 1 | 2011 | 116 | 0.090 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 302 | 0.090 |
Why?
|
| New York City | 2 | 2010 | 710 | 0.090 |
Why?
|
| Aging | 3 | 2017 | 8664 | 0.090 |
Why?
|
| Levodopa | 1 | 2011 | 219 | 0.090 |
Why?
|
| Compulsive Behavior | 1 | 2011 | 117 | 0.090 |
Why?
|
| Oligospermia | 1 | 2010 | 59 | 0.090 |
Why?
|
| Milk | 1 | 2013 | 450 | 0.090 |
Why?
|
| Culture Media | 1 | 2012 | 909 | 0.090 |
Why?
|
| Nitric Oxide | 3 | 2003 | 2132 | 0.090 |
Why?
|
| Mothers | 1 | 2021 | 2165 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2018 | 2036 | 0.090 |
Why?
|
| Antiparkinson Agents | 1 | 2011 | 184 | 0.090 |
Why?
|
| Dominican Republic | 1 | 2009 | 76 | 0.090 |
Why?
|
| Organ Size | 2 | 2013 | 2251 | 0.090 |
Why?
|
| Treatment Outcome | 14 | 2021 | 63107 | 0.090 |
Why?
|
| Cadmium Poisoning | 1 | 2009 | 11 | 0.090 |
Why?
|
| Fetal Mortality | 1 | 2009 | 19 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2012 | 631 | 0.090 |
Why?
|
| Incidence | 8 | 2021 | 20952 | 0.090 |
Why?
|
| Affective Symptoms | 1 | 2012 | 407 | 0.090 |
Why?
|
| Reproductive Health Services | 1 | 2010 | 80 | 0.090 |
Why?
|
| Climate Change | 1 | 2015 | 418 | 0.090 |
Why?
|
| Carbon | 2 | 2003 | 687 | 0.090 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2009 | 25 | 0.090 |
Why?
|
| Fires | 2 | 2008 | 173 | 0.090 |
Why?
|
| Protective Devices | 1 | 2009 | 71 | 0.080 |
Why?
|
| Anthropometry | 3 | 2019 | 1350 | 0.080 |
Why?
|
| Delusions | 1 | 2011 | 300 | 0.080 |
Why?
|
| Hair Preparations | 2 | 2010 | 32 | 0.080 |
Why?
|
| United States | 17 | 2021 | 69872 | 0.080 |
Why?
|
| Urinalysis | 2 | 2015 | 369 | 0.080 |
Why?
|
| Vanadium | 2 | 2005 | 53 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3595 | 0.080 |
Why?
|
| Didanosine | 1 | 2008 | 153 | 0.080 |
Why?
|
| Hallucinations | 1 | 2011 | 360 | 0.080 |
Why?
|
| Theophylline | 1 | 2008 | 132 | 0.080 |
Why?
|
| Commerce | 1 | 2014 | 592 | 0.080 |
Why?
|
| Hand | 1 | 2014 | 884 | 0.080 |
Why?
|
| Adiposity | 1 | 2018 | 1806 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 577 | 0.080 |
Why?
|
| Trophoblasts | 1 | 2010 | 215 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2011 | 980 | 0.080 |
Why?
|
| Beauty Culture | 1 | 2008 | 41 | 0.080 |
Why?
|
| Smoking | 5 | 2019 | 8987 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 15520 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2887 | 0.080 |
Why?
|
| Welding | 2 | 2005 | 89 | 0.080 |
Why?
|
| Attention | 1 | 2018 | 2397 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3307 | 0.080 |
Why?
|
| Rescue Work | 1 | 2008 | 56 | 0.080 |
Why?
|
| Family Characteristics | 3 | 2018 | 1000 | 0.080 |
Why?
|
| Endocrine System | 1 | 2008 | 113 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2019 | 13035 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 974 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 807 | 0.070 |
Why?
|
| Fetal Development | 1 | 2013 | 767 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 1607 | 0.070 |
Why?
|
| Israel | 2 | 2021 | 796 | 0.070 |
Why?
|
| Amniotic Fluid | 2 | 2007 | 370 | 0.070 |
Why?
|
| Child Welfare | 1 | 2011 | 523 | 0.070 |
Why?
|
| Immunoassay | 2 | 2008 | 752 | 0.070 |
Why?
|
| Birth Rate | 2 | 2019 | 170 | 0.070 |
Why?
|
| Obstetric Labor Complications | 1 | 2009 | 238 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2013 | 1183 | 0.070 |
Why?
|
| Overweight | 2 | 2021 | 2371 | 0.070 |
Why?
|
| New England | 4 | 2020 | 1022 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1701 | 0.070 |
Why?
|
| Weight Gain | 1 | 2016 | 2293 | 0.070 |
Why?
|
| Metallurgy | 4 | 2008 | 94 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2020 | 8551 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 857 | 0.070 |
Why?
|
| Meat-Packing Industry | 1 | 2005 | 12 | 0.070 |
Why?
|
| Hydrocarbons | 1 | 2006 | 106 | 0.070 |
Why?
|
| Risk Management | 1 | 2009 | 571 | 0.070 |
Why?
|
| Estrogens | 1 | 2013 | 1566 | 0.070 |
Why?
|
| Health Surveys | 3 | 2013 | 4036 | 0.070 |
Why?
|
| Bangladesh | 2 | 2017 | 687 | 0.070 |
Why?
|
| Labor, Obstetric | 1 | 2009 | 333 | 0.070 |
Why?
|
| Infant | 7 | 2021 | 35134 | 0.070 |
Why?
|
| Educational Status | 1 | 2013 | 2540 | 0.070 |
Why?
|
| Cognition | 2 | 2013 | 6770 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2020 | 571 | 0.060 |
Why?
|
| Sperm Tail | 1 | 2004 | 18 | 0.060 |
Why?
|
| Gonadotropins | 2 | 2016 | 241 | 0.060 |
Why?
|
| Endometrium | 2 | 2019 | 424 | 0.060 |
Why?
|
| Prescription Drugs | 1 | 2011 | 595 | 0.060 |
Why?
|
| Steroids | 1 | 2010 | 930 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2019 | 6077 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 1456 | 0.060 |
Why?
|
| Industry | 2 | 2003 | 365 | 0.060 |
Why?
|
| Meiosis | 2 | 2019 | 339 | 0.060 |
Why?
|
| Hygiene | 1 | 2004 | 97 | 0.060 |
Why?
|
| Cooking | 2 | 2016 | 313 | 0.060 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2003 | 77 | 0.060 |
Why?
|
| Motor Activity | 1 | 2014 | 2715 | 0.060 |
Why?
|
| Incineration | 1 | 2003 | 20 | 0.060 |
Why?
|
| Pregnant Women | 2 | 2020 | 568 | 0.060 |
Why?
|
| Trauma Severity Indices | 2 | 2002 | 481 | 0.060 |
Why?
|
| Ontario | 2 | 2014 | 383 | 0.060 |
Why?
|
| Pyrenes | 1 | 2003 | 46 | 0.060 |
Why?
|
| Refuse Disposal | 1 | 2003 | 31 | 0.060 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 233 | 0.060 |
Why?
|
| Selection Bias | 1 | 2005 | 371 | 0.060 |
Why?
|
| Mental Recall | 1 | 2009 | 1206 | 0.060 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2004 | 281 | 0.060 |
Why?
|
| Heating | 1 | 2003 | 97 | 0.060 |
Why?
|
| Population | 1 | 2003 | 142 | 0.050 |
Why?
|
| Algorithms | 3 | 2019 | 13882 | 0.050 |
Why?
|
| Retrospective Studies | 9 | 2021 | 77460 | 0.050 |
Why?
|
| Cities | 2 | 2019 | 513 | 0.050 |
Why?
|
| Data Collection | 2 | 2009 | 3339 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9445 | 0.050 |
Why?
|
| Quality Control | 1 | 2005 | 841 | 0.050 |
Why?
|
| Metals, Heavy | 1 | 2003 | 139 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2021 | 41005 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12262 | 0.050 |
Why?
|
| Task Performance and Analysis | 2 | 2009 | 780 | 0.050 |
Why?
|
| Safety Management | 1 | 2008 | 783 | 0.050 |
Why?
|
| Aged | 13 | 2019 | 163288 | 0.050 |
Why?
|
| Endometriosis | 1 | 2010 | 839 | 0.050 |
Why?
|
| Tanzania | 2 | 2016 | 1346 | 0.050 |
Why?
|
| Zinc | 2 | 2003 | 684 | 0.050 |
Why?
|
| Beta Particles | 1 | 2021 | 50 | 0.050 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 723 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3873 | 0.050 |
Why?
|
| Phenol | 1 | 2021 | 43 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 2184 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2005 | 1794 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5077 | 0.050 |
Why?
|
| Research Design | 2 | 2019 | 5984 | 0.050 |
Why?
|
| Silicones | 1 | 2021 | 250 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2011 | 21748 | 0.050 |
Why?
|
| Demography | 1 | 2005 | 1655 | 0.050 |
Why?
|
| Skin Tests | 1 | 2002 | 613 | 0.050 |
Why?
|
| Diet, Mediterranean | 2 | 2019 | 700 | 0.040 |
Why?
|
| Parents | 2 | 2019 | 3405 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8642 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 73 | 0.040 |
Why?
|
| Respiratory System | 1 | 2003 | 557 | 0.040 |
Why?
|
| Esters | 1 | 2020 | 210 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2019 | 27 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2004 | 694 | 0.040 |
Why?
|
| Creatinine | 1 | 2005 | 1919 | 0.040 |
Why?
|
| Linuron | 1 | 2019 | 3 | 0.040 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 65 | 0.040 |
Why?
|
| Spirometry | 1 | 2002 | 865 | 0.040 |
Why?
|
| Receptors, sigma | 1 | 2019 | 28 | 0.040 |
Why?
|
| Luciferases | 1 | 2021 | 733 | 0.040 |
Why?
|
| Poly A | 1 | 2019 | 185 | 0.040 |
Why?
|
| Denmark | 1 | 2021 | 738 | 0.040 |
Why?
|
| Weights and Measures | 1 | 2018 | 43 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2004 | 851 | 0.040 |
Why?
|
| Rats, Inbred WKY | 3 | 2003 | 158 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 719 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2005 | 1318 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 293 | 0.040 |
Why?
|
| Gene Library | 1 | 2021 | 1074 | 0.040 |
Why?
|
| Women | 1 | 2020 | 230 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 1341 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2011 | 10252 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2016 | 6366 | 0.040 |
Why?
|
| Consensus | 1 | 2007 | 2960 | 0.040 |
Why?
|
| Risk | 3 | 2019 | 9688 | 0.040 |
Why?
|
| Cholesterol | 2 | 2019 | 2919 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3617 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2019 | 296 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 2204 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2002 | 1745 | 0.040 |
Why?
|
| Workplace | 1 | 2003 | 836 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2019 | 229 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2002 | 672 | 0.040 |
Why?
|
| X Chromosome Inactivation | 1 | 2019 | 224 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 798 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2019 | 3589 | 0.040 |
Why?
|
| Netherlands | 2 | 2014 | 2170 | 0.040 |
Why?
|
| Government Regulation | 1 | 2021 | 522 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 1342 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2021 | 1997 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 871 | 0.030 |
Why?
|
| Medical Records | 2 | 2017 | 1413 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15078 | 0.030 |
Why?
|
| Ghana | 1 | 2017 | 284 | 0.030 |
Why?
|
| Progesterone | 1 | 2020 | 775 | 0.030 |
Why?
|
| Public Health | 1 | 2009 | 2602 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 711 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2016 | 61 | 0.030 |
Why?
|
| Arteries | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Ecosystem | 1 | 2020 | 474 | 0.030 |
Why?
|
| Patient Participation | 1 | 2005 | 1457 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2017 | 513 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 1151 | 0.030 |
Why?
|
| Lung | 3 | 2003 | 9857 | 0.030 |
Why?
|
| Administration, Inhalation | 3 | 2003 | 1105 | 0.030 |
Why?
|
| Poultry | 1 | 2015 | 82 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1915 | 0.030 |
Why?
|
| Myocarditis | 1 | 2003 | 771 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2019 | 729 | 0.030 |
Why?
|
| Premenopause | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Metabolome | 1 | 2021 | 895 | 0.030 |
Why?
|
| Microvessels | 1 | 2019 | 544 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 940 | 0.030 |
Why?
|
| Smoke | 1 | 2016 | 227 | 0.030 |
Why?
|
| Shellfish | 1 | 2014 | 38 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 913 | 0.030 |
Why?
|
| Compomers | 1 | 2014 | 6 | 0.030 |
Why?
|
| Diet Records | 1 | 2016 | 425 | 0.030 |
Why?
|
| Child Care | 1 | 2015 | 119 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2019 | 711 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 26388 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5749 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 854 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 1725 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 570 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 802 | 0.030 |
Why?
|
| Zirconium | 1 | 2014 | 101 | 0.030 |
Why?
|
| Probability | 1 | 2019 | 2506 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 834 | 0.030 |
Why?
|
| Inflammation | 3 | 2019 | 10637 | 0.030 |
Why?
|
| Ectogenesis | 1 | 2012 | 8 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2439 | 0.030 |
Why?
|
| Genomics | 2 | 2019 | 5717 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2014 | 213 | 0.030 |
Why?
|
| Rats, Inbred SHR | 2 | 2003 | 195 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 850 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 4740 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 505 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1707 | 0.030 |
Why?
|
| Polybrominated Biphenyls | 1 | 2012 | 28 | 0.030 |
Why?
|
| Breath Tests | 2 | 2003 | 280 | 0.030 |
Why?
|
| Environment | 1 | 2019 | 1123 | 0.030 |
Why?
|
| Prevalence | 3 | 2019 | 15221 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2008 | 585 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2013 | 76 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2014 | 244 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 2013 | 245 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2020 | 1350 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2013 | 117 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 9955 | 0.030 |
Why?
|
| Taiwan | 1 | 2013 | 496 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2004 | 1911 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2013 | 209 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2012 | 265 | 0.030 |
Why?
|
| North America | 1 | 2015 | 1249 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2015 | 749 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 320 | 0.020 |
Why?
|
| Suction | 1 | 2012 | 267 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 277 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2902 | 0.020 |
Why?
|
| Nebraska | 1 | 2010 | 35 | 0.020 |
Why?
|
| Menarche | 1 | 2014 | 516 | 0.020 |
Why?
|
| RNA Stability | 1 | 2013 | 321 | 0.020 |
Why?
|
| Workload | 1 | 2017 | 849 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1088 | 0.020 |
Why?
|
| Deodorants | 1 | 2010 | 3 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 81201 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2003 | 9145 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 768 | 0.020 |
Why?
|
| Genome | 1 | 2019 | 1807 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2012 | 647 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 596 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 6994 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2012 | 468 | 0.020 |
Why?
|
| Ohio | 1 | 2010 | 337 | 0.020 |
Why?
|
| Albumins | 2 | 2002 | 568 | 0.020 |
Why?
|
| Myocardium | 1 | 2003 | 4772 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 954 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2009 | 46 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2009 | 62 | 0.020 |
Why?
|
| Testis | 1 | 2013 | 804 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 1617 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2010 | 211 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3508 | 0.020 |
Why?
|
| Breech Presentation | 1 | 2009 | 44 | 0.020 |
Why?
|
| Insect Control | 1 | 2008 | 28 | 0.020 |
Why?
|
| Cockroaches | 1 | 2008 | 96 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3338 | 0.020 |
Why?
|
| Species Specificity | 2 | 2003 | 2478 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3084 | 0.020 |
Why?
|
| Gene Expression | 2 | 2013 | 7798 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2011 | 968 | 0.020 |
Why?
|
| Manufactured Materials | 1 | 2007 | 19 | 0.020 |
Why?
|
| Cytokines | 1 | 2003 | 7323 | 0.020 |
Why?
|
| Protective Clothing | 1 | 2008 | 102 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2014 | 1086 | 0.020 |
Why?
|
| Ventilation | 1 | 2008 | 127 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11486 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2019 | 3280 | 0.020 |
Why?
|
| Cell Separation | 1 | 2013 | 1751 | 0.020 |
Why?
|
| Animals, Wild | 1 | 2007 | 90 | 0.020 |
Why?
|
| Genitalia, Female | 1 | 2008 | 146 | 0.020 |
Why?
|
| Zebrafish | 1 | 2019 | 2996 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2933 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 380 | 0.020 |
Why?
|
| United States Environmental Protection Agency | 1 | 2007 | 139 | 0.020 |
Why?
|
| North Carolina | 1 | 2007 | 315 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12952 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 2453 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3519 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 3966 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2011 | 6442 | 0.020 |
Why?
|
| Leptin | 1 | 2014 | 1600 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 977 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2065 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 2098 | 0.020 |
Why?
|
| Threshold Limit Values | 1 | 2005 | 10 | 0.020 |
Why?
|
| Polyvinyl Chloride | 1 | 2005 | 34 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 1958 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6194 | 0.020 |
Why?
|
| Hypertension | 2 | 2002 | 8479 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1678 | 0.020 |
Why?
|
| Respiratory Protective Devices | 1 | 2005 | 45 | 0.020 |
Why?
|
| Alberta | 1 | 2005 | 64 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2010 | 648 | 0.020 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2005 | 56 | 0.020 |
Why?
|
| Midwestern United States | 1 | 2005 | 70 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2015 | 1185 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 1892 | 0.020 |
Why?
|
| Maximum Allowable Concentration | 1 | 2005 | 62 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20824 | 0.020 |
Why?
|
| Kidney | 1 | 2021 | 7184 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16690 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3954 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 16000 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 8300 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 18034 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 3079 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2012 | 1809 | 0.010 |
Why?
|
| Healthy Worker Effect | 1 | 2003 | 29 | 0.010 |
Why?
|
| Transition Elements | 1 | 2003 | 18 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 780 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2017 | 5984 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2003 | 227 | 0.010 |
Why?
|
| Liver | 1 | 2019 | 7475 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2002 | 32 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19233 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2327 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2003 | 226 | 0.010 |
Why?
|
| Oils | 1 | 2002 | 63 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2618 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2009 | 2539 | 0.010 |
Why?
|
| Causality | 1 | 2009 | 1275 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2019 | 23404 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 644 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 2002 | 403 | 0.010 |
Why?
|
| Motor Vehicles | 1 | 2003 | 268 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4751 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2005 | 600 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4468 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29060 | 0.010 |
Why?
|
| Occupational Health Services | 1 | 2002 | 154 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 6036 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 57776 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21833 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2173 | 0.010 |
Why?
|
| Macrophages, Alveolar | 1 | 2003 | 407 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 288 | 0.010 |
Why?
|
| Swine | 1 | 2010 | 5918 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2008 | 1828 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2009 | 1365 | 0.010 |
Why?
|
| Laboratories | 1 | 2004 | 463 | 0.010 |
Why?
|
| Aerosols | 1 | 2002 | 625 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2009 | 2241 | 0.010 |
Why?
|
| Insulin | 1 | 2014 | 6582 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 3646 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 3658 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2002 | 894 | 0.010 |
Why?
|
| Breast | 1 | 2008 | 1970 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 1186 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2003 | 1101 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2585 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1461 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2011 | 2775 | 0.010 |
Why?
|
| Respiration | 1 | 2003 | 1653 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15535 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 2624 | 0.010 |
Why?
|
| Fibrosis | 1 | 2003 | 2029 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 3582 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7147 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2003 | 1887 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5974 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2008 | 3309 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4245 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2004 | 1947 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 12073 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 3721 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 4464 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2002 | 2789 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 9724 | 0.000 |
Why?
|
| Neoplasms | 1 | 2009 | 21696 | 0.000 |
Why?
|